-
If your practice includes care of pregnant women, be sure they are being tested for chlamydia and gonorrhea. Results of a new national analysis of laboratory tests of 1.3 million pregnant women indicate just 59% and 57% of pregnant women were tested at least once for chlamydia and gonorrhea, respectively.
-
Results of a paper presented at the recent Annual Clinical Meeting of the American College of Obstetricians and Gynecologists suggest that an investigational low-dose contraceptive patch appears to be as effective as a combined oral contraceptive (COC).1
-
Results of primary studies on and meta-analyses of the effects of vitamin D therapy on fracture risk have failed to conclusively demonstrate benefit.
-
Several studies have implicated endometriosis as a risk factor for the subsequent development of invasive epithelial ovarian cancer.
-
In this issue: Side effects of finasteride; new ruling on pharmaceutical companies paying generic manufacturers; and FDA actions.
-
Patients who received treatment for depression within a year were identified in a Japanese database of more than 323,000 patients. The investigators asked 2354 patients to complete a questionnaire on depression with a specific focus on patient-physician relationships.
-
-
Every so often, one runs across a paper that is somewhat offbeat, but could have some beneficial clinical implications. One such article appeared recently in the British Journal of Obstetrics and Gynecology that dealt with a way to possibly counter the fetal effects of maternal hyperthermia and even protect the brains of fetuses/infants against potential hypoxic insult during labor.
-
Through the contraceptive choice project, the authors performed a prospective cohort study in which 9256 women living in the region surrounding St. Louis, Missouri, received a reversible contraceptive method of their choice for up to 3 years at no cost.
-
A new policy statement issued by the American Academy of Pediatrics and backed by the American College of Obstetricians and Gynecologists states that the health benefits of circumcision in newborn males outweigh any risks and insurance companies should pay for it.